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was largely a function of early patient education and early refer-Determinants of type and timing of initial permanent hemodi-
ral to a nephrologist.alysis vascular access.
Background. We undertook a population-based study of
hemodialysis (HD) patients to determine which factors are
important in predicting the type of permanent access initially Maintenance of vascular access in hemodialysis (HD)
placed and if a functional permanent access is in place at the
patients is an enormous public health problem, costingstart of HD.
Medicare close to $1 billion per year [1, 2]. To address thisMethods. Selected characteristics were abstracted from the
United States Renal Data System (USRDS) Dialysis Morbidity problem, the Dialysis Outcome Quality Initiative (DOQI)
and Mortality Study (DMMS) Wave 2. Logistic regression was work group on vascular access was created to developed
used to estimate the independent contribution of specific char- practice guidelines. The primary types of permanent vas-
acteristics in predicting whether the initial permanent access
cular access include the autogenous arteriovenous (AV)placed was an arteriovenous (AV) fistula compared with a
fistula and the polytetrafluoroethylene (PTFE) graft. Vas-polytetrafluoroethylene (PTFE) graft, and in predicting whether
cular access may also be temporarily maintained by apermanent access (fistula or graft) was in place at the initiation
of dialysis. tunneled cuffed catheter or a double-lumen percutane-
Results. Sixty-seven percent of the patients had an AV graft ously inserted catheter. The report from the DOQI work
placed as their first permanent access. Characteristics important group recommends that patients be referred for surgery toin predicting if a fistula was initially placed included age (per
construct an autogenous AV fistula when their creatininedecade; aOR 5 0.84, P , 0.001), female gender (aOR 5 0.52,
clearance is ,25 mL/min and their serum creatinine isP , 0.001), body mass index (per standard deviation; aOR 5
0.70, P 5 0.09), avoiding blood draws (aOR 5 1.96, P , 0.001), .4 mg/dL or within one year of anticipated need for HD.
ability to ambulate (aOR 5 2.24, P 5 0.008), underlying renal This is to allow time for placement and maturation of the
disease (glomerular compared with diabetes, aOR 5 2.19, P 5 access and prevents the need for a temporary catheter
0.009), college education (aOR 5 1.72, P 5 0.002), and sharing
[3]. AV fistulas are associated with higher patency ratesin decision making (aOR 5 1.50, P 5 0.02). Thirty-four percent
and lower rates of infection than PTFE grafts. For thisof patients (34.4%) had functional permanent access at the start
of HD. Characteristics important in predicting which patients reason, the DOQI work group recommends that the order
had functional permanent access included serum albumin (per of preference should be the radial-cephalic AV fistula
1 mg/dL increase, aOR 51.55, P 5 0.003), erythropoietin prior followed by brachial-cephalic AV fistula. If it is not possi-
to starting HD (aOR 5 1.79, P 5 0.002), fewer predialysis
ble to place these types of accesses, either a transposednephrologist visits (aOR 5 0.21, P , 0.001), and when the
brachial-basilic vein fistula or a PTFE graft should bepatient was told they had renal disease (aOR 5 0.33, P 5 0.002).
considered. The DOQI work group further recommendsConclusions. PTFE grafts were the most common initial per-
manent access. The majority of patients did not have permanent that construction of the AV fistula should be timed so
access at the start of dialysis. Factors that are thought to compro- that the fistula has at least one month and ideally three
mise identification of adequate veins were important predictors to four months to mature prior to cannulation. Amongof PTFE graft placement. Permanent access at the start of HD
patients who are not candidates for AV fistulas, PTFE
grafts should be placed at least three to six weeks prior
to an anticipated need for HD.Key words: arteriovenous fistula, PTFE graft, veins for dialysis, hemo-
dialysis. Although most nephrologists support these recommen-
dations, PTFE grafts continue to be the most commonReceived for publication June 17, 1999
initial permanent access created, and most end-stage renaland in revised form August 26, 1999
Accepted for publication September 9, 1999 disease (ESRD) patients do not have a functional perma-
nent access at the time they initiate HD [4–6]. The factorsÓ 2000 by the International Society of Nephrology
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Table 1. Selected characteristics of patient populationimpacting the choice of access initially created and the
presence of functional permanent access at the initiation N (%)
of HD are not well defined. Characterizing these factors Age
,55 years 621 (32)may suggest interventions to increase the proportion of
55–70 years 701 (36)AV fistulas placed and the number of patients with per-
.70 years 618 (32)
manent access at the start of HD. Such interventions Race
White 1126 (58)may decrease the impact of vascular access maintenance
Black 660 (34)on the total cost of ESRD care. We undertook a popula-
Other 166 (8)
tion-based study of HD patients using data from the Male gender 1039 (53)
Diabetes 986 (51)United States Renal Data System (USRDS) Dialysis
Peripheral vascular disease 350 (19)Morbidity and Mortality Study (DMMS) Wave 2 to de-
Heart disease 664 (37)
termine which factors are important in predicting the
type of permanent access initially placed and which fac-
tors determine whether a functional permanent access
is in place at the start of HD. phritis, other), coronary artery disease (yes, no), periph-
eral vascular disease (yes, no), and diabetes (yes, no).
The body mass index was calculated from height andMETHODS
weight. Outcome variables ascertained for the analysis
Data collection
included the first permanent access created or attempted
Data for this study were obtained from the USRDS no more than 60 days after the start of dialysis (fistula,
DMMS Wave 2. Details of the design of the DMMS PTFE graft, catheter), the date of surgery for the first
Wave 2 study are described in detail elsewhere [6]. In permanent access created, the vascular access in use at
short, USRDS DMMS is an observational study in which the initiation of dialysis (fistula, PTFE graft, catheter),
demographic, comorbidity, laboratory, treatment, and and the vascular access in use 60 days after the start of
socioeconomic data are collected using dialysis records dialysis (fistula, PTFE graft, catheter). Patients who had
from a random sample of ESRD patients. DMMS Wave a bovine graft placed were excluded from the analysis.
2 is a prospective study in which a random sample of
dialysis patients incident in 1996 were selected from 25% Statistical analysis
of the dialysis units listed in the December 1993 Master Logistic regression was used to estimate the indepen-
List in addition to all new dialysis units opening after dent contribution of demographic, behavioral, and medi-
January 1, 1994. Patients were excluded if they were cal history variables in predicting the odds that the first
younger than 18 years, if they were home dialysis pa- permanent access placed was an AV fistula compared
tients, or if they had been previously transplanted. Mod- with a PTFE graft. Logistic regression was also used to
ality assignment was determined on day 60 of ESRD. estimate the independent contribution of demographic,
All HD patients were selected for this study. behavioral, and medical history variables in predicting
Dialysis facility personnel abstracted data for patients the odds that permanent access was in use (AV fistulas
from dialysis records. Demographics and behavioral or PTFE grafts) at the start of dialysis. Tunneled cathe-
characteristics used in our analysis included date of birth, ters were not considered permanent access. The esti-
race (white, black, other), gender, education (some high mated standard error of the coefficient (B1) from the
school or high school graduate, some college, or college logistic regression analysis was used to establish confi-
graduate), employment status (employed, not employed), dence intervals. Data were analyzed with SPSS statistical
marital status (married, not married), and tobacco use software (SPSS, Chicago, IL, USA).
(active, former, never), and exercise (frequently, occa-
sionally, never). Variables related to the patients kidney
RESULTSdisease included the date of first dialysis, the process of
choosing the initial treatment for kidney failure (patient Characteristics of the patient population are summa-
rized in Table 1. Five hundred and five (33%) patientstook lead, medical team took the lead, medical team and
patient jointly took the lead), how long prior to starting had an AV fistula, and 955 (67%) had an AV graft placed
as their first permanent access. Permanent access wasdialysis the patient was told about his or her renal disease
(.1 year, 1 to 12 months, 1 to 4 weeks, ,1 week), placed at a mean of 27.2 6 105.2 days prior to the start
of dialysis (AV fistula 5 42.5 6 128 days and PTFEwhether the patient was told to avoid blood draws (yes,
no), and how many visits the patient made to a nephrolo- graft 5 19.1 6 90.1 days). Fifty-five percent (N 5 778)
of permanent accesses were placed before the initiationgist prior to starting dialysis (.5 visits, 2 to 4 visits, 1 visit,
no visits). Medical history ascertained included cause of of HD, and 45% (N 5 646) were placed after. Of those
permanent accesses placed before the initiation of HD,kidney disease (diabetes, hypertension, glomerulone-
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Table 2. Odds of having an AV fistula compared to a PTFE graft created as the first permanent access
Covariate N 5 1449 OR (95% CI) P value aOR (95% CI)a P value
Age decades 1435 0.82 (0.77, 0.89) ,0.001 0.84 (0.76, 0.93) ,0.001
,55 years 469 1
55–70 years 536 0.50 (0.39, 0.65) ,0.001 0.53 (0.37, 0.82) ,0.001
.70 years 430 0.52 (0.40, 0.69) ,0.001 0.55 (0.37, 0.82) 0.003
Gender 1449
Female 655 0.39 (0.31, 0.49) ,0.001 0.52 (0.38, 0.72) ,0.001
Body mass index per standard deviation 1368 0.67 (0.49, 0.92) 0.01 0.70 (0.47, 1.06) 0.09
Avoid blood draws 394 2.08 (1.60, 2.72) ,0.001 1.96 (1.44, 2.67) ,0.001
Able to ambulate independently 1219 2.82 (1.96, 4.06) ,0.001 2.24 (1.23, 4.09) 0.008
Underlying renal disease ,0.001 ,0.001
Diabetes 654 1 1
Hypertension 407 1.26 (0.96, 1.64) 0.09 1.08 (0.75, 1.57) 0.67
Glomerulonephritis 99 2.47 (1.61, 3.80) ,0.001 2.19 (1.21, 3.97) 0.009
Other 207 1.88 (1.41, 2.52) ,0.001 2.09 (1.38, 3.15) ,0.001
Education
Some high school or high school graduate 992 1 1
Some college or college graduate 317 1.74 (1.35, 2.26) ,0.001 1.72 (1.22, 2.41) 0.002
Method of modality choice 0.06 0.04
Medical team took the lead 504 1 1
Medical team and patient took the lead 297 1.54 (1.14, 2.07) 0.004 1.50 (1.06, 2.12) 0.02
Patient took the lead 177 1.34 (0.94, 1.92) 0.11 0.95 (0.62, 1.46) 0.83
Coronary artery disease 1344 0.79 (0.62, 0.99) 0.05
Peripheral vascular disease 1342 0.70 (0.52, 0.94) 0.02
Cholesterol per 10 mg/dL 1308 0.98 (0.95, 0.99) 0.03
Widowed 1449 0.53 (0.40, 0.72) ,0.001
Living in nursing home 1449 0.46 (0.27, 0.77) 0.003
Black ethnicity (compared to Caucasian) 1441 0.73 (0.57, 0.92) 0.009
Abbreviations are: OR, odds ratio; CI, confidence interval; aOR, adjusted odds ratio.
a Adjusted for age, gender, body mass index, avoid blood draws, ability to ambulate, underlying renal disease, education, and method of modality choice
the mean time between placement and start of HD was to receive an AV fistula than a PTFE graft (adjusted
OR 5 2.19, 95% CI 1.21, 3.97; P 5 0.009). Patients who56.4 6 126.1 days (AV fistula 5 81.1 6 150.0 days and
PTFE graft 5 43.1 6 109.0 days). Of those permanent had had some college education were 1.72-fold more
likely to receive an AV fistula than those who had a highaccess placed after the start of HD, the mean time be-
tween placement and start of HD was 215.5 6 21.4 days school education or less (adjusted OR 5 1.72, 95% CI
1.22, 2.41; P 5 0.002). Sharing in decision making with(AV fistula 5 216.4 6 27.6 days and PTFE graft 5
215.0 6 17.5 days). the medical team regarding the choice of treatment mo-
dality resulted in a 50% higher likelihood of receivingIn the final model, the characteristics important in
predicting the type of permanent access initially placed an AV fistula compared with those patients who did not
participate in decision making (adjusted OR 5 1.50, CI(AV fistula vs. PTFE graft) are described in Table 2.
For every decade increase in age, patients were 16% less 1.06, 2.12; P 5 0.02).
In the univariate analysis, the history of coronary ar-likely to receive a fistula than a PTFE graft (adjusted
OR 5 0.84; 95% CI 0.76, 0.93, P , 0.001). Women were tery disease (OR 5 0.79, 95% CI 0.62, 0.99; P 5 0.05),
peripheral vascular disease (OR 5 0.70, 95% CI 0.52,48% less likely than men to receive a fistula (adjusted
OR 5 0.52, 95% CI 0.38, 0.72; P , 0.001). For every 0.94; P 5 0.02), higher cholesterol (per 10 mg/dL, OR 5
0.98, 95% CI 0.95, 0.99; P 5 0.03), being widowed (ad-one standard deviation increase in body mass index from
the mean of the study population, patients were 30% justed OR 5 0.53, 95% CI 0.40, 0.72; P , 0.001), living
in a nursing home (adjusted OR 5 0.46, 95% CI 0.27,less likely to receive an AV fistula than a PTFE graft
(adjusted OR 5 0.70, 95% CI 0.47, 1.06; P 5 0.09). 0.77; P 5 0.003), and black ethnicity (compared with
white ethnicity; adjusted OR 5 0.73, 95% CI 0.57, 0.92;Patients who had been told to avoid blood draws were
almost two-fold more likely to receive an AV fistula P 5 0.009) decreased the likelihood of having an AV
fistula placed as the initial access (Table 2). However,(adjusted OR 5 1.96, 95% CI 1.44, 2.67; P , 0.001).
The ability to ambulate conferred a two-fold increased after adjusting for age, gender, body mass index, avoiding
blood draws, ability to ambulate, underlying renal dis-likelihood of receiving an AV fistula compared with a
PTFE graft (adjusted OR 5 2.24, 95% CI 1.23, 4.09; ease, education, and method of modality choice, these
variables were no longer statistically significant andP 5 0.008). Patients whose underlying renal disease was
secondary to glomerulonephritis were twofold more therefore were not included in the final model. The se-
rum triglyceride level, neoplasm, employment status andlikely than those with renal disease caused by diabetes
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Table 3. Odds of having functional permanent access at the start of hemodialysis
Covariate N 5 1909 OR (95% CI) P value aOR (95% CI)a P value
Age decades 1878 1.05 (0.99, 1.11) 0.14 1.10 (0.99, 1.22) 0.08
,55 years 606 1 1
55–70 years 681 1.31 (1.03, 1.65) 0.02 1.39 (0.96, 2.01) 0.08
.70 years 600 1.13 (0.89, 1.44) 0.33 1.29 (0.87, 1.90) 0.21
Serum albumin per mg/dL 1810 1.58 (1.31, 1.89) ,0.001 1.55 (1.16, 2.08) 0.003
Use of erythropoetin prior to starting HD 1668 2.04 (1.58, 2.65) ,0.001 1.79 (1.23, 2.61) 0.002
Visits to a nephrologist prior to starting HD ,0.001 ,0.001
.5 464 1 1
2–5 268 0.63 (0.46, 0.85) 0.003 0.73 (0.50, 1.05) 0.09
1 94 0.28 (0.16, 0.47) ,0.001 0.21 (0.10, 0.43) ,0.001
0 319 0.21 (0.15, 0.29) ,0.001 0.36 (0.23, 0.57) ,0.001
When patient was told about renal disease ,0.001
.1 year before start of hemodialysis 589 1 ,0.001 1
1–12 months before start of hemodialysis 391 0.67 (0.51, 0.87) 0.003 0.93 (0.66, 1.31) 0.69
1–4 weeks before start of hemodialysis 108 0.23 (0.13, 0.40) ,0.001 0.33 (0.16, 0.68) 0.002
,1 week before start of hemodialysis 114 0.09 (0.04, 0.19) ,0.001 0.16 (0.06, 0.42) ,0.001
Body mass index per SD 1760 1.18 (1.00, 1.40) 0.05
History of diabetes 1867 1.26 (1.04, 1.53) 0.02
Hematocrit at start of dialysis per SD 1850 1.16 (1.05, 1.28) 0.004
Ability to independently ambulate 1889 1.44 (1.10, 1.87) 0.02
Method of modality choice 1226 ,0.001
Medical team took the lead 1
Medical team and patient took the lead 1.03 (1.00, 1.74) 0.04
Patient took the lead 2.36 (1.72, 3.25) ,0.001
Abbreviations are: OR, odds ratio; CI, confidence interval; aOR, adjusted odds ratio.
a Adjusted for race, gender, age, serum albumin, use of erythropoietin, number of visits to a nephrologist prior to starting HD, and when the patient was told
about the renal disease
insurance status were not independent predictors, and 1.18, 95% CI 1.00, 1.40; P 5 0.05), a history of diabetes
(OR 5 1.26, 95% CI 1.04, 1.53; P 5 0.02), hematocrittherefore were not included in the final model.
Six hundred and fifty-seven (34.4%) patients had per- at the start of dialysis (per standard deviation; OR 5
1.16, 95% CI 1.05, 1.28; P 5 0.004), and the ability tomanent access in use at the start of HD. Characteristics
important in predicting which patients had permanent ambulate independently (OR 5 1.44, 95% CI 1.10, 1.87;
P 5 0.008) were significant predictors of having perma-access in use at the start of HD are described in Table
3. For every 1 mg/dL increase in serum albumin, patients nent access in use at the start of HD. In addition, patients
who took the lead in decision making were twofold morewere 55% more likely to have permanent access in use
at the start of HD (adjusted OR 5 1.55, 95% CI 1.16, likely to have usable permanent access at the start of
dialysis (OR 5 2.37; 95% CI 1.72, 3.25; P , 0.001).2.08; P 5 0.003). Those patients who had received eryth-
ropoietin during the 30 days prior to starting HD were However, after adjusting for demographic and comorbid
conditions, these variables were no longer statistically79% more likely to have permanent access in use at the
start of HD (adjusted OR 5 1.79, 1.23, 2.61; P 5 0.002). significant and therefore were not included in the final
model. Serum blood urea nitrogen at the start of dialysis,Fewer visits to a nephrologist prior to the start of the
dialysis decreased the likelihood of having permanent serum creatinine at the start of dialysis, history of heart
disease, education level, insurance status, and race wereaccess in use at the start of HD. For example, patients
who had one visit to a nephrologist were 79% less likely not significant predictors and therefore were not in-
cluded in the final model.to have permanent access in use at the start of dialysis
than those with more than five visits (adjusted OR 5 The type of vascular access in use both at the start
and 60 days after the initiation of HD was available for0.21, 95% CI 0.10, 1.43; P , 0.001). Patients who were
told they had renal disease earlier were more likely to 1805 patients. The distribution of vascular access in use
at these time points is shown in Table 4. At the start ofhave permanent access in use at the start of HD. For
example, patients who were told they had renal disease HD, 66% of patients were using a catheter. Eleven per-
cent were using an AV fistula, and 22% were using aone to four weeks prior to the start of HD were 67%
less likely to have permanent access in use at the start PTFE graft as their primary vascular access. Two months
after the start of HD, 32% of patients were using aof HD than those that were told more than one year
before the start of HD (aOR 5 0.33, 95% CI 0.16, 0.68; catheter. Nineteen percent were using an AV fistula, and
49% were using a PTFE graft as their primary access.P 5 0.002).
In the univariate analysis, the body mass index (OR 5 Of the 1195 patients who were using a catheter as their
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Table 4. Change in access type between the initiation and demonstrated superior patency rates and lower rates of
hemodialysis and 60 days after the start of dialysis
infection with AV fistulas compared with PTFE grafts,
Access in use at initiation of dialysis even among older patients [8, 9]. Although the increasing
Catheter PTFE graft AV fistula Total burden of comorbidities among ESRD patients may
Access in use 60 days number number number number make placement of fistulas technically more difficult,
after initiation row % row % row %
studies have shown that implementation of policies toof dialysis column % column % column % column %
decrease PTFE graft placement results in greater propor-Catheter
tions of AV fistulas placed among all patient subgroups,Number 554 19 11 584
Row % 94% 3% 2% without adversely affecting patency rates [10, 11]. In
Column % 46% 5% 5% 32% order to meet and assess the impact of the DOQI recom-PTFE graft
Number 483 380 14 877 mendations, policies aimed at increasing fistula place-
Row % 55% 43% 2% ment should be implemented and evaluated to determine
Column % 40% 94% 7% 49%
the long-term impact on morbidity.AV fistula
Number 158 4 182 344 Our data are consistent with a previous report, which
Row % 46% 1% 53% determined factors important in determining the type of
Column % 13% 1% 88% 19%
functioning access 60 days after the start of dialysis. This
Total number 1195 403 207 1805 study reported that increasing age, female gender, dia-Row % 66% 22% 12%
betic nephropathy, larger body mass, and inability to
ambulate were associated with a lower likelihood of hav-
ing an AV fistula in use 60 days after the start of dialysis
[7]. Although older patients are more likely to haveprimary access at the start of HD, 60 days after the start
vascular disease, older age does not necessarily resultof HD, 554 (46%) were still using a catheter; 483 (40%)
in poorer patency outcomes. Access survival data havewere using a PTFE graft, and 158 (13%) were using an
suggested that among patients greater than 65 years ofAV fistula.
age, AV fistulas have a 24% lower risk of failure than
grafts (adjusted OR 5 0.76, 95% CI 0.60, 0.96; P 5 0.02)
DISCUSSION [8]. Female ESRD patients and patients with a larger
body mass index were also less likely to receive an AVPolytetrafluoroethylene grafts are more commonly
fistula. This may reflect the smaller caliber of veins foundplaced at the initiation of dialysis than AV fistulas, and
in women, deeper vessels in obese patients, and vascularmost patients did not have permanent access in use at
disease among diabetics, each compromising the abilitythe start of dialysis. Factors that have been hypothesized
to locate adequate veins for AV fistula placement. Al-to compromise the ability to identify adequate veins were
though there is a general consensus that age, gender,found to increase the likelihood of PTFE graft place-
diabetes, body size, and general health impact the sizement. Patients who were more informed and who had
and quality of veins available for the creation of a fistula,more proactive nephrologists were more likely to have
the impact of these factors on access survival is not wella fistula placed. Only 34% of patients had permanent
defined. Careful evaluation of these factors and strate-access in use at the start of HD. This was largely a
gies to improve localization of veins among patients with-function of how early patients became aware of their
out obvious adequate veins should be undertaken.kidney disease and how soon they were referred to a
Patients who are more educated and who shared innephrologist. Half of the patients requiring catheters at
the decision making with their nephrologist were morethe start of HD continued to use catheters two months
likely to receive an AV fistula, independent of otherlater. The majority of the remaining patients were using
comorbid conditions. This may reflect socioeconomicPTFE grafts. Of those that had an AV fistula or PTFE
status and the degree to which the patient is informedgraft in use at the start of HD, most were using the same
form of access 60 days later. about options for vascular access. Patients told to avoid
blood draws were also more likely to receive an AVTwo thirds of incident patients in 1996 had a PTFE
graft placed as their initial access. This is higher than fistula. This may reflect both a nephrologist preference
for fistulas and result in less compromise to veins. Thereported among incident patients in either 1986, 1987,
or 1990 (56%) and is consistent with the trend toward number of visits to a nephrologist before the start of
dialysis was not associated with type of access placed,an increasing proportion of PTFE grafts initially placed
for dialysis access [7]. The increasing proportion of PTFE although it was associated with likelihood of usable per-
manent access at the start of dialysis. This suggests thatgrafts placed is of concern. In 1997, the DOQI work-
group recommended that 50% of accesses placed should physician practice patterns play a greater role in choosing
which type of access is placed and that timing of referralbe AV fistulas. This was based on literature that has
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to the nephrologist plays a greater role in the likelihood personnel who may not have been able to determine
of having usable assess at the initiation of HD. with complete accuracy the type of access initially placed
The likelihood of having usable permanent access at prior to the start of dialysis. If dialysis personnel were
the start of HD was largely a function of how well the not aware that a patient initially had a fistula placed that
patient had been integrated into the medical system prior failed to mature and subsequently had a PTFE graft
to starting dialysis. The more limited the number of visits placed, the number of fistulas initially placed may be
to a nephrologist and the shorter the time between being underestimated. However, medical records were re-
informed about renal disease and starting dialysis, the viewed, and both abstractors and physicians were al-
less likely that a patient had permanent access at the lowed to ask patients questions in order to complete the
start of HD. In addition, those patients that had begun forms accurately. Although this study does have limita-
erythropoietin more than 30 days prior to the start of tions, to our knowledge this is the first study to assess
dialysis were more likely to have usable permanent ac- predictors of the first permanent access placed and hav-
cess at the start of dialysis. This may reflect patients for ing permanent usable access at the start of dialysis. In
whom a pre-ESRD evaluation had been implemented. addition, the population-based design of this study allows
These data support the general consensus that late refer- generalizability to the entire dialysis population and does
ral to the nephrologist is associated with adverse out- not reflect institution-specific practices.
comes. Serum albumin was also an important predictor We have identified factors that predict the type of
of having usable access at the start of HD and may reflect access initially placed and that predict which patients
the state of health of the patient. The decision to undergo
have permanent access in use at the start of dialysis. It is
dialysis may be made later among those patients who
possible that some of these factors do, in fact, technicallyare in particularly poor health, thus limiting the time
preclude the successful placement of fistulas, whereasbetween access placement and the start of dialysis. Socio-
other factors may identify patients in which fistula place-economic factors such as race and education were not
ment is technically possible and interventions could in-significant independent predictors of having usable ac-
crease their use. Studies are needed to evaluate thecess at the start of dialysis.
impact of interventions designed to increase fistulasOur data support the perception that the later a patient
placement and increase the likelihood that permanentis referred for access placement, the more likely they
access is in use at the start of dialysis.are to have a catheter placed for initial access followed
by a PTFE graft. Of the patients who were using a cathe-
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